What is Amgen's common stock, shares authorized (in shares)?

Amgen (AMGN) reported common stock, shares authorized (in shares) of $2.75B in Q1 2026.

How has Amgen's common stock, shares authorized (in shares) changed year-over-year?

Amgen's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $2.75B to $2.75B.

What is the long-term trend for Amgen's common stock, shares authorized (in shares)?

Over 5 years (2020 to 2025), Amgen's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $2.75B to $2.75B.

Amgen AMGN Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Nektar TherapeuticsNKTR

——

Oruka Therapeutics, Inc.ORKA

——

Rigel PharmaceuticalsRIGL

——

AbbVieABBV

——

Roivant SciencesROIV

——

Tango TherapeuticsTNGX

——

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

EPS (diluted)$3.34+4.4%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total equity$9.2B+48.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$195.44B+34.6%

Enterprise value$252.2B+25.7%

P/E25.1×+3.1×

P/S5.3×+1.1×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

FCF margin23.1%-8.9pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's common stock, shares authorized (in shares)?: Amgen (AMGN) reported common stock, shares authorized (in shares) of $2.75B in Q1 2026.
How has Amgen's common stock, shares authorized (in shares) changed year-over-year?: Amgen's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $2.75B to $2.75B.
What is the long-term trend for Amgen's common stock, shares authorized (in shares)?: Over 5 years (2020 to 2025), Amgen's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $2.75B to $2.75B.